NEWS: C&W aim to promote clinical trials

Cohn and Wolfe’s healthcare division has launched a service for pharmaceutical companies to encourage patients to participate in clinical trials.

Cohn and Wolfe’s healthcare division has launched a service for

pharmaceutical companies to encourage patients to participate in

clinical trials.



Inform, unveiled this week at the British Association of Pharmaceutical

Physicians, was developed by the PR agency with pharmaceutical giants

SmithKline Beecham and Du Pont.



Cohn and Wolfe has invested a six-figure-sum in the launch, hiring two

staff and conducting research among the pharmaceutical industry to gauge

responses to the service, the first of its kind.



The service, which will operate from Cohn and Wolfe’s offices, aims to

reduce delays in clinical trials - with the consequent delays in product

licensing and loss of profits - by combating public suspicion of the

process.



It plans to develop materials for use by medical investigators heading

the trials including slides, pamphlets and flip charts.



The aim is to increase the pool of patients available and minimise the

drop-out rate by providing ‘patient-friendly’ information.



‘Most medical jargon is not understood by the man on the street and

won’t inspire confidence in trials,’ said Martin Ellis, director of Cohn

and Wolfe Healthcare.



‘We need to re-educate the consumer to expel the myth that patients are

guinea pigs’.



To bring a product onto the market takes an average of 12 years.

Companies need 2,000 to 3,000 patients to apply for a marketing license

and the process can cost approximately pounds 200m.



Ellis is aiming to give companies a head start before a product comes

off patent and opens up to competitors.



‘A week of delay is a week of sales lost forever,’ he said.



Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Interpublic PR group claims double-digit growth in Q1 revenues

Interpublic PR group claims double-digit growth in Q1 revenues

Interpublic Group's PR agency unit saw double-digit revenue growth in the first quarter of 2014, according to Weber Shandwick CEO Andy Polansky.

Max Clifford trial jury sent home after fourth day of deliberations

Max Clifford trial jury sent home after fourth day of deliberations

The jury in the trial of celebrity publicist Max Clifford has been sent home to reconvene tomorrow for further deliberations about its verdicts on 11 charges of indecent assault.

Omnicom turns in 1.2 per cent growth in Q1 PR revenues

Ketchum parent group Omnicom has reported 1.2 per cent organic revenue growth at its PR division for the first quarter of 2014.

British Airways retains Grayling for Europe and Asia

British Airways retains Grayling for Europe and Asia

British Airways has reappointed Grayling as its retained PR agency for 39 European and Asia-Pacific markets following a competitive pitch.